NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti‐CD3 antibody

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1832-1842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

By Villiers T.   Chines A.   Palacios S.   Lips P.   Sawicki A.   Levine A.   Codreanu C.   Kelepouris N.   Brown J.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 567-576

Springer Publishing Company

Access to resources Recommend Favorite

Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial

By Frakes E.P.   Risser R.C.   Ball T.D.   Hochberg M.C.   Wohlreich M.M.  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2361-2372

Informa Healthcare

Access to resources Recommend Favorite

Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1782-1792

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 3, 2015-03 ,pp. : 295-306

John Wiley & Sons Inc

Access to resources Recommend Favorite